GGrantIndex
Sort

326,823 grants matching clinical trial

SPIRRIT-HFPEF - CCC

$1,669,447
Eric David Peterson · Duke University · U01 · FY2019 · HL

Mitigation of the Catecholamine Surge in Severely Burned Patients

$1,669,435
David N Herndon · University Of Texas Med Br Galveston · P50 · FY2013 · GM

Clinical evaluation of BMS-984923 metabolism.

$1,669,100
Timothy R Siegert · Allyx Therapeutics Inc. · SB1 · FY2025 · AG

Improving Patient Reported Outcome Data for Research through Seamless Integration of the PROMIS Toolkit into EHR Workflows

$1,669,069
Justin B Starren · Northwestern University At Chicago · U01 · FY2016 · TR

NCI Community Oncology Research Program (NCORP) Minority/Underserved Community Sites

$1,668,973
Carolyn Y Muller · University Of New Mexico Health Scis Ctr · UG1 · FY2022 · CA

Clinical Investigations of Sjogren's Syndrome

$1,668,957
Ilias Alevizos · National Institute Of Dental & Craniofacial Research · ZIA · FY2012 · DE

Role of Viral Reservoirs in the Pathogenesis of HIV Disease

$1,668,909
Tae-Wook Chun · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI

Clinical Center for Look AHEAD: Health in Diabetes

$1,668,825
University Of Colorado Denver · U01 · FY2002 · DK

CLINICAL PHARMACOLOGY QUALITY ASSURANCE

$1,668,783
Eugene Morse · State University Of New York At Buffalo · N01 · FY2020 · AI

Women's Health Study: Continued Follow-up

$1,668,675
Julie E Buring · Brigham And Women'S Hospital · R01 · FY2006 · CA

Optimizing Colonoscopy & Fecal Immunochemical Tests for Community-Based Screening

$1,668,673
Douglas Allen Corley · Kaiser Foundation Research Institute · U54 · FY2015 · CA

MULTICENTER VITAMIN E TRIAL-PERSONS WITH DOWN SYNDROME

$1,668,552
Institute For Basic Res In Dev Disabil · R01 · FY2004 · AG

NINDS Cooperative Program in Translational Research

$1,668,536
Mary P Stenzel-Poore · Oregon Health & Science University · U01 · FY2010 · NS

PHASE II/III trial for Slowing Progression in Mild Cognitive Impairment

$1,668,503
Michela Gallagher · Johns Hopkins University · R01 · FY2016 · AG

ACISR for Late-Life Depression Prevention

$1,668,501
Charles F Reynolds · University Of Pittsburgh At Pittsburgh · P30 · FY2013 · MH

University of Cincinnati AIDS Clinical Trials Unit- UC ACTU

$1,668,393
Carl J Fichtenbaum · University Of Cincinnati · UM1 · FY2012 · AI

Repurposing an EU Therapeutic for Hemoglobinopathies

$1,668,330
Sharie Haugabook · National Center For Advancing Translational Sciences · ZIA · FY2023 · TR

Physical Activity to Improve CV Health in Women: A Pragmatic Trial CCC-Lead

$1,668,277
Marcia L Stefanick · Stanford University · U01 · FY2016 · HL

Quality Assurance Review Center

$1,668,186
Thomas J Fitzgerald · Univ Of Massachusetts Med Sch Worcester · U10 · FY2011 · CA

Improved Oral P-selectin Blocker for Prophylactic Sickle Cell Disease Therapy

$1,668,155
Stephen H. Embury · Vanguard Therapeutics, Inc. · R44 · FY2016 · HL

Quality Assurance Review Center

$1,668,149
Thomas J Fitzgerald · Univ Of Massachusetts Med Sch Worcester · U10 · FY2012 · CA

MSKCC -Cornell Center for Translation of Cancer Nanomedicines.

$1,668,143
Michelle S Bradbury · Sloan-Kettering Inst Can Research · U54 · FY2015 · CA

CTSA INFRASTRUCTURE FOR CLINICAL TRIALS

$1,668,141
Richard S Larson · University Of New Mexico · UL1 · FY2010 · RR

National Institute of Arthritis and Musculoskeletal and Skin Diseases Clinical Studies Management and Support

$1,667,949
Kathy Dimeo · Kai Research, Inc · N01 · FY2017 · HL

Comprehensive dissection of the CLL genome & phenome to improve patient outcomes

$1,667,862
Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · P01 · FY2021 · CA